Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2014 Annual Meeting | 4ES.001 - The Intractable Headache Patient

Tuesday 04/29/14
02:00 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Extended Seminar
Charles C. Flippen II, MD, FÂ鶹´«Ã½Ó³»­
Participants should be able to recognize and treat medication overuse headache, including using proper detoxification strategies, employing specific outpatient and inpatient treatment strategies for the difficult-to-treat headache patient, having the clinical skills to treat patients with intractable migraine headaches, and understanding when the use of adjunctive interventional methods advance the patients care .
No CME available
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic
Event Timeline
02:00 PM - 02:50 PM Evaluation of the Intractable Headache Patient
Charles C. Flippen II, MD, FÂ鶹´«Ã½Ó³»­
02:55 PM - 03:45 PM Interventional Techniques for the Intractable Headache Patient - Nerve Blockade
Morris Levin, MD, FÂ鶹´«Ã½Ó³»­
03:45 PM - 04:00 PM Break
04:00 PM - 04:45 PM Interventional Therapies to Aid the Intractable Headache Patient
Abraham A. Ashkenazi, MD
04:45 PM - 05:00 PM Questions and Answers
Faculty Disclosures
Charles C. Flippen II, MD, FÂ鶹´«Ã½Ó³»­ Dr. Flippen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Carelon. Dr. Flippen has a non-compensated relationship as a committee member with American Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Flippen has a non-compensated relationship as a committee/task force member with American Neurological Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Morris Levin, MD, FÂ鶹´«Ã½Ó³»­ Dr. Levin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus, Upsher Smith, Biohaven, Revance, Percept, Theranica, Allergan, Alder, Currax. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Attorney . Dr. Levin has received stock or an ownership interest from Percept. Dr. Levin has received publishing royalties from a publication relating to health care.
Abraham A. Ashkenazi, MD No disclosure on file